A Phase 1 Open-Label Study to Evaluate Safety, Pharmacokinetics, and Preliminary anti- Tumor Activity of STRO-004 in Adults with Refractory/Recurrent Metastatic Solid Tumors

16780STRO-004-ST1-NCT07227168OpenA Phase 1 Open-Label Study to Evaluate Safety, Pharmacokinetics, and Preliminary anti- Tumor Activity of STRO-004 in Adults with Refractory/Recurrent Metastatic Solid TumorsSTRO-004-ST1NCT07227168IndustrialAdultTreatmentIMultipleReuss, JoshuaGeorgetown University Medical Center; Lombardi Comprehensive Cancer CenterPhase IOncology GroupLombardi Comprehensive Cancer Center (LCCC); Oncology PFS2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>